WASHINGTON: US Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd that would have prevented a lower court ruling from going into effect while the court considers an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.
The decision could help pave the way for generic competitors to go on the market as soon as next month
Comments
Comments are closed.